Eoin O'Brien

PROGRESS Management Committee. PROGRESS: Perindopril Protection Against Recurrent Stroke Study: Status in March 1997. J Human Hypertens 1998;12:627-629

Chalmers J, Neal B, MacMahon S on behalf of the PROGRESS Management Committee. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. J Hypertens 2000;18 (Suppl 1):S13-S19.

Tzourio C, Anderson C for the PROGRESS Management Committee. Blood pressure reduction and risk of dementia in patients with stroke in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). J Hypertens 2000;18 (Suppl 1):S21-S24.

PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041

PROGRESS Collaborative Group. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. European Heart J 2003;24:475-484

Rodgers A, Chapman N, Woodward M, Liu L-S, Colman S, Lee A, Chalmers J, MacMahon S, on behalf of the PROGRESS Collaborative Group. Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. J Hypertens 2004, 22:653–659

Berthet K, Neal BC, Chalmers JP, MacMahon S, Bousser G, Colman SA, Woodward M on behalf of the PROGRESS Collaborative Group. Blood Pressure 2004;13:7-13

N. Chapman M. Woodward. Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial. Stroke 2004;35: 116 – 121

Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, MacMahon S, Neal B for the PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006, 24:1201–1208